A new study published in the journal Gastroenterology suggests that genetic variation in our ability to digest ... now a ...

A diagnostic test developed by researchers at the University of California San Francisco aims to help physicians identify causes of severe infections by analyzing DNA and RNA to detect a range of ...

Type 2 diabetes has become one of the fastest-growing health challenges worldwide, affecting millions across all age groups.

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the human ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

As the company restructures, it will pivot to selling genetic tests to consumers and using that data for research. Also: medicinal and tech advancements in cancer care; research monkeys roundup.